JHVEPhoto
While much of the S&P 500 has enjoyed robust gains over the past 12 months, the Health Care sector has been a mixed bag. At home, Eli Lilly (LLY) dominates, now in the top 10 in terms of largest domestic companies by market cap, while other drug manufacturers have struggled to execute and build their pipelines. Medical Devices firms likewise have not found a solid footing as the sector realigns itself post-pandemic.
I am upgrading shares of Edwards Lifesciences Corporation (NYSE:EW). I see the stock has a better value today given better EPS growth trends while its momentum remains murky.
S&P 500 1-Year Performance Heat Map: Medical Device Stocks Mixed
Finviz
According to Bank of America Global Research, Edwards Lifesciences provides devices and technologies for structural heart disease, and critical care and surgical monitoring. EW is a leader in transcatheter heart valve replacement – one of the most visible,…
